PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ITCI vs. VOO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between ITCI and VOO is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

ITCI vs. VOO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Intra-Cellular Therapies, Inc. (ITCI) and Vanguard S&P 500 ETF (VOO). The values are adjusted to include any dividend payments, if applicable.

0.00%20.00%40.00%60.00%80.00%SeptemberOctoberNovemberDecember2025February
72.86%
10.51%
ITCI
VOO

Key characteristics

Sharpe Ratio

ITCI:

1.30

VOO:

1.89

Sortino Ratio

ITCI:

3.12

VOO:

2.54

Omega Ratio

ITCI:

1.38

VOO:

1.35

Calmar Ratio

ITCI:

3.75

VOO:

2.83

Martin Ratio

ITCI:

8.03

VOO:

11.83

Ulcer Index

ITCI:

8.71%

VOO:

2.02%

Daily Std Dev

ITCI:

53.73%

VOO:

12.66%

Max Drawdown

ITCI:

-87.64%

VOO:

-33.99%

Current Drawdown

ITCI:

-0.05%

VOO:

-0.42%

Returns By Period

In the year-to-date period, ITCI achieves a 53.90% return, which is significantly higher than VOO's 4.17% return. Over the past 10 years, ITCI has outperformed VOO with an annualized return of 17.58%, while VOO has yielded a comparatively lower 13.26% annualized return.


ITCI

YTD

53.90%

1M

1.61%

6M

72.86%

1Y

75.41%

5Y*

39.23%

10Y*

17.58%

VOO

YTD

4.17%

1M

1.23%

6M

10.51%

1Y

24.45%

5Y*

14.68%

10Y*

13.26%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ITCI vs. VOO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ITCI
The Risk-Adjusted Performance Rank of ITCI is 9090
Overall Rank
The Sharpe Ratio Rank of ITCI is 8484
Sharpe Ratio Rank
The Sortino Ratio Rank of ITCI is 9292
Sortino Ratio Rank
The Omega Ratio Rank of ITCI is 9090
Omega Ratio Rank
The Calmar Ratio Rank of ITCI is 9696
Calmar Ratio Rank
The Martin Ratio Rank of ITCI is 8888
Martin Ratio Rank

VOO
The Risk-Adjusted Performance Rank of VOO is 7979
Overall Rank
The Sharpe Ratio Rank of VOO is 7979
Sharpe Ratio Rank
The Sortino Ratio Rank of VOO is 7676
Sortino Ratio Rank
The Omega Ratio Rank of VOO is 7878
Omega Ratio Rank
The Calmar Ratio Rank of VOO is 7979
Calmar Ratio Rank
The Martin Ratio Rank of VOO is 8282
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ITCI vs. VOO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Intra-Cellular Therapies, Inc. (ITCI) and Vanguard S&P 500 ETF (VOO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for ITCI, currently valued at 1.30, compared to the broader market-2.000.002.001.301.89
The chart of Sortino ratio for ITCI, currently valued at 3.12, compared to the broader market-4.00-2.000.002.004.006.003.122.54
The chart of Omega ratio for ITCI, currently valued at 1.38, compared to the broader market0.501.001.502.001.381.35
The chart of Calmar ratio for ITCI, currently valued at 3.75, compared to the broader market0.002.004.006.003.752.83
The chart of Martin ratio for ITCI, currently valued at 8.03, compared to the broader market-10.000.0010.0020.0030.008.0311.83
ITCI
VOO

The current ITCI Sharpe Ratio is 1.30, which is lower than the VOO Sharpe Ratio of 1.89. The chart below compares the historical Sharpe Ratios of ITCI and VOO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00SeptemberOctoberNovemberDecember2025February
1.30
1.89
ITCI
VOO

Dividends

ITCI vs. VOO - Dividend Comparison

ITCI has not paid dividends to shareholders, while VOO's dividend yield for the trailing twelve months is around 1.19%.


TTM20242023202220212020201920182017201620152014
ITCI
Intra-Cellular Therapies, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VOO
Vanguard S&P 500 ETF
1.19%1.24%1.46%1.69%1.25%1.54%1.88%2.06%1.78%2.02%2.10%1.85%

Drawdowns

ITCI vs. VOO - Drawdown Comparison

The maximum ITCI drawdown since its inception was -87.64%, which is greater than VOO's maximum drawdown of -33.99%. Use the drawdown chart below to compare losses from any high point for ITCI and VOO. For additional features, visit the drawdowns tool.


-12.00%-10.00%-8.00%-6.00%-4.00%-2.00%0.00%SeptemberOctoberNovemberDecember2025February
-0.05%
-0.42%
ITCI
VOO

Volatility

ITCI vs. VOO - Volatility Comparison

The current volatility for Intra-Cellular Therapies, Inc. (ITCI) is 0.95%, while Vanguard S&P 500 ETF (VOO) has a volatility of 2.94%. This indicates that ITCI experiences smaller price fluctuations and is considered to be less risky than VOO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%35.00%SeptemberOctoberNovemberDecember2025February
0.95%
2.94%
ITCI
VOO
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab